GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Signify Health Inc (NYSE:SGFY) » Definitions » Peter Lynch Fair Value

Signify Health (Signify Health) Peter Lynch Fair Value : N/A (As of Jun. 03, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Signify Health Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Signify Health's Peter Lynch Fair Value or its related term are showing as below:



SGFY's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.315
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Signify Health Peter Lynch Fair Value Historical Data

The historical data trend for Signify Health's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Signify Health Peter Lynch Fair Value Chart

Signify Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Peter Lynch Fair Value
- - - - -

Signify Health Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Signify Health's Peter Lynch Fair Value

For the Health Information Services subindustry, Signify Health's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Signify Health's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Signify Health's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Signify Health's Price-to-Peter-Lynch-Fair-Value falls into.



Signify Health Peter Lynch Fair Value Calculation

Signify Health's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *0.434
=N/A

Signify Health's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $0.43.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Signify Health  (NYSE:SGFY) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Signify Health's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=30.49/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Signify Health Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Signify Health's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Signify Health (Signify Health) Business Description

Traded in Other Exchanges
N/A
Address
800 Connecticut Avenue, 3rd Floor, Norwalk, CT, USA, 06854
Signify Health Inc is a healthcare technology company that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. The customers include health plans, governments, employers, health systems and physician groups. Its operating segment includes Home and Community Services and Episodes of Care Services. The company generates maximum revenue from the Home and Community Services segment.
Executives
David Pierre officer: Chief Operating Officer 800 CONNECTICUT AVENUE, NORWALK CT 06854
Paymon Farazi officer: Chief Product Officer C/O SIGNIFY HEALTH, INC., 800 CONNECTICUT AVE, NORWALK CT 06854
Tim Gronniger officer: Ch. Value-Based Sols. Off C/O SIGNIFY HEALTH, INC., 800 CONNECTICUT AVE, NORWALK CT 06854
Vivian E. Riefberg director 800 CONNECTICUT AVENUE, NORWALK CT 06854
Adam Mcananey officer: General Counsel and Secretary 800 CONNECTICUT AVENUE, NORWALK CT 06854
Marc D Rothman officer: Chief Medical Officer 800 CONNECTICUT AVENUE, NORWALK CT 06854
Kyle B. Peterson director 800 CONNECTICUT AVENUE, NORWALK CT 06854
Taj J. Clayton director 800 CONNECTICUT AVENUE, NORWALK CT 06854
Josh Builder officer: Chief Technology Officer 800 CONNECTICUT AVENUE, NORWALK CT 06854
Heather Brianne Dixon director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Steve Senneff officer: Pres. Chief Fin. & Admin. Off. C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Bradford Kyle Armbrester director, officer: Chief Executive Officer 311 ARSENAL STREET, WATERTOWN MA 02472
Albert A Notini director C/O DELTEK, INC., 2291 WOOD OAK DRIVE, HERNDON VA 20171
Kevin M Mcnamara director 2200 DON TYSON PARKWAY, SPRINGDALE AR 72762
Matthew S. Holt director C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019